Reduced caloric intake and dehydration: Retatrutide suppresses appetite, which may in some individuals lead to a reduction in food and fluid intake
Dose calculation errors account for 11.3% of adverse events reported with compounded GLP-1 medications, most commonly from switching pharmacies without recalculating unit counts (Johnson et al., Clinical Toxicology 2025)
This is particularly relevant because hypoxic tumours are known to exhibit increased resistance to radiotherapy and certain systemic therapies (190, 191), and therefore, imaging hypoxia has potential implications for treatment planning and prognostic assessment
Development of more efficient production methods or alternative formulations may be necessary to address these constraints
In the UK, D-allulose is classified as a novel food and requires authorisation from the Food Standards Agency (FSA) before widespread commercial use, with specific conditions of use that must be followed
When your GLP-1 signal is weak, you may feel hungry again quickly, even after a big meal, and it can feel like you need extra willpower just to eat normally